OFI Advisors’s Novo Nordisk NVO Stock Holding History

OFI Advisors’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$65K	Sell	2,404 -126	-5%	-$3.57K	﹤0.01%	1560
2015 Q2	$69K	Sell	2,530 -172	-6%	-$4.83K	﹤0.01%	1559
2015 Q1	$72K	Buy	2,702 +126	+5%	+$2.9K	﹤0.01%	1561
2014 Q4	$55K	Buy	2,576 +264	+11%	+$5.9K	﹤0.01%	1590
2014 Q3	$55K	Sell	2,312 -132	-5%	-$3.04K	﹤0.01%	1590
2014 Q2	$56K	Buy	2,444 +72	+3%	+$1.59K	﹤0.01%	1580
2014 Q1	$54K	Sell	2,372 -588	-20%	-$12.5K	﹤0.01%	1574
2013 Q4	$55K	Sell	2,960 -10	-0.3%	-$174	﹤0.01%	1570
2013 Q3	$50K	Sell	2,970 -360	-11%	-$6.05K	﹤0.01%	1557
2013 Q2	$52K	Buy	+3,330	New	+$55.4K	0.01%	1507

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

OFI Advisors's NVO Position: Q3 2015 in Review

OFI Advisors reduced its Novo Nordisk (NVO) stake by 5% in Q3 2015, selling an estimated $3.57K and leaving 2,404 shares worth $65K. The position accounts for ﹤0.01% of the portfolio, ranked #1560.

OFI Advisors first reported a position in NVO in Q2 2013 and has held it in 10 quarters since. The position peaked at $72K in Q1 2015. 525 funds tracked by Wall St. Rank hold NVO as of Q3 2015.

OFI Advisors held 2,404 shares of Novo Nordisk worth $65K as of Q3 2015.
OFI Advisors sold 126 Novo Nordisk shares in Q3 2015, an estimated $3.57K.
Novo Nordisk made up ﹤0.01% of OFI Advisors's portfolio in Q3 2015, its #1560 holding.
OFI Advisors first reported a position in Novo Nordisk in Q2 2013 and has held it in 10 quarters since.
OFI Advisors's Novo Nordisk position peaked at $72K in Q1 2015.
525 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.